Tt International Asset Management LTD Moderna, Inc. Transaction History

Tt International Asset Management LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$101.21 - $166.61 $121,451 - $199,932	-1,200 Reduced 8.28%	13,300 $1.58 Million
Q1 2024 May 14, 2024	BUY	$85.37 - $115.44 $42,685 - $57,720	500 Added 3.57%	14,500 $1.55 Million
Q4 2023 Feb 29, 2024	BUY	$69.51 - $104.43 $417,060 - $626,580	6,000 Added 75.0%	14,000 $1.39 Million
Q3 2023 Nov 14, 2023	SELL	$96.41 - $126.61 $255,486 - $335,516	-2,650 Reduced 24.88%	8,000 $826,000
Q2 2023 Aug 01, 2023	BUY	$118.5 - $160.53 $373,275 - $505,669	3,150 Added 42.0%	10,650 $1.29 Million
Q1 2023 May 10, 2023	BUY	$135.66 - $197.02 $1.02 Million - $1.48 Million	7,500 New	7,500 $1.15 Million

952

241M

10.6M

18.7M

Ticker MRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 391,200,000
Market Cap $16.1B
Description
Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...

Get notified when there are updates to the investment portfolio of Tt International Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Tt International Asset Management LTD with notifications on news.